scispace - formally typeset
P

Priscilla Ross

Researcher at University of California, Irvine

Publications -  7
Citations -  418

Priscilla Ross is an academic researcher from University of California, Irvine. The author has contributed to research in topics: Antigen & Skin biopsy. The author has an hindex of 5, co-authored 7 publications receiving 394 citations.

Papers
More filters
Journal ArticleDOI

Cell Proliferation in Normal Epidermis

TL;DR: A kinetic model for epidermal cell renewal in normal epidermis is described that interrelates the rate of birth/entry, transit, and/or loss of keratinocytes in the 3Epidermal compartments: proliferative, viable differentiated (stratum malpighii ), and stratum corneum.
Journal ArticleDOI

Cell kinetic basis for pathophysiology of psoriasis.

TL;DR: The short 36-h duration of the psoriatic cell cycle (Tc) is confirmed with the first double-peaked fraction of labeled mitoses (FLM) curve in human subjects, and the growth fraction of psoriasis using two experimental techniques approximates 100% within 36 h, confirming the rapid Tc found by the FLM method.
Journal ArticleDOI

Immunopathology of cutaneous human lupus erythematosus defined by murine monoclonal antibodies.

TL;DR: It is suggested that a T lymphocyte-mediated immune response associated with a reduction in Langerhans cells and capillary endothelium HLA-DR antigens is involved in the inflammatory process of lupus erythematosus skin.
Journal ArticleDOI

Scanning acoustic microscopy of neoplastic and inflammatory cutaneous tissue specimens.

TL;DR: The advantages of the R-SAM include the capability of producing an acoustic profile of the tissue and the future possibility of in situ diagnosis and the capability to make a specific diagnosis primarily from low magnification pattern analysis.
Journal Article

A Novel Approach for Obtaining and Identifying Monoclonal Antibodies That React with Differentiation-specific Antigens Using Human Hybrid Cells

TL;DR: Use of hybrid cells derived from HeLa X differentiated cell fusions as immunogens should prove to be a general method for identifying differentiation-specific antigens from a variety of differentiated cell types.